1
|
Van Dyke TE and Serhan CN: Resolution of
inflammation: a new paradigm for the pathogenesis of periodontal
diseases. J Dent Res. 82:82–90. 2003.PubMed/NCBI
|
2
|
Pozo P, Valenzuela MA, Melej C, et al:
Longitudinal analysis of metalloproteinases, tissue inhibitors of
metalloproteinases and clinical parameters in gingival crevicular
fluid from periodontitis-affected patients. J Periodontal Res.
40:199–207. 2005. View Article : Google Scholar
|
3
|
DeCarlo AA Jr, Windsor LJ, Bodden MK, et
al: Activation and novel processing of matrix metalloproteinases by
a thiol-proteinase from the oral anaerobe Porphyromonas
gingivalis. J Dent Res. 76:1260–1270. 1997. View Article : Google Scholar : PubMed/NCBI
|
4
|
Fentoğlu Ö, Köroğlu BK, Hiçyılmaz H, et
al: Pro-inflammatory cytokine levels in association between
periodontal disease and hyperlipidaemia. J Clin Periodontol.
38:8–16. 2011.PubMed/NCBI
|
5
|
Vernal R, Dezerega A, Dutzan N, et al:
RANKL in human periapical granuloma: possible involvement in
periapical bone destruction. Oral Dis. 12:283–289. 2006. View Article : Google Scholar : PubMed/NCBI
|
6
|
Cazalis J, Tanabe S, Gagnon G, Sorsa T and
Grenier D: Tetracyclines and chemically modified tetracycline-3
(CMT-3) modulate cytokine secretion by
lipopolysaccharide-stimulated whole blood. Inflammation.
32:130–137. 2009. View Article : Google Scholar : PubMed/NCBI
|
7
|
Sorsa T, Tjäderhane L, Konttinen YT, et
al: Matrix metalloproteinases: contribution to pathogenesis,
diagnosis and treatment of periodontal inflammation. Ann Med.
38:306–321. 2006. View Article : Google Scholar : PubMed/NCBI
|
8
|
Birkedal-Hansen H: Role of cytokines and
inflammatory mediators in tissue destruction. J Periodontal Res.
28:500–510. 1993. View Article : Google Scholar : PubMed/NCBI
|
9
|
Uitto VJ, Overall CM and McCulloch C:
Proteolytic host cell enzymes in gingival crevice fluid.
Periodontol 2000. 31:77–104. 2003. View Article : Google Scholar : PubMed/NCBI
|
10
|
Okada H and Murakami S: Cytokine
expression in periodontal health and disease. Crit Rev Oral Biol
Med. 9:248–266. 1998. View Article : Google Scholar : PubMed/NCBI
|
11
|
Hirano T, Akira S, Taga T and Kishimoto T:
Biological and clinical aspects of interleukin 6. Immunol Today.
11:443–449. 1990. View Article : Google Scholar : PubMed/NCBI
|
12
|
Ishimi Y, Miyaura C, Jin CH, et al: IL-6
is produced by osteoblasts and induces bone resorption. J Immunol.
145:3297–3303. 1990.PubMed/NCBI
|
13
|
Baggiolini M, Walz A and Kunkel SL:
Neutrophil-activating peptide-1/interleukin 8, a novel cytokine
that activates neutrophils. J Clin Invest. 84:1045–1049. 1989.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Bastos MF, Lima JA, Vieira PM, et al:
TNF-alpha and IL-4 levels in generalized aggressive periodontitis
subjects. Oral Dis. 15:82–87. 2009. View Article : Google Scholar : PubMed/NCBI
|
15
|
Dongari-Bagtzoglou AI and Ebersole JL:
Increased presence of interleukin-6 (IL-6) and IL-8 secreting
fibroblast subpopulations in adult periodontitis. J Periodontol.
69:899–910. 1998. View Article : Google Scholar : PubMed/NCBI
|
16
|
César-Neto JB, Duarte PM, de Oliveira MC,
et al: Smoking modulates interleukin-6:interleukin-10 and
RANKL:osteoprotegerin ratios in the periodontal tissues. J
Periodontal Res. 42:184–191. 2007.PubMed/NCBI
|
17
|
Ribeiro FV, de Mendonça AC, Santos VR, et
al: Cytokines and bone-related factors in systemically healthy
patients with chronic periodontitis and patients with type 2
diabetes and chronic periodontitis. J Periodontol. 82:1187–1196.
2011. View Article : Google Scholar : PubMed/NCBI
|
18
|
Javed F, Al-Askar M and Al-Hezaimi K:
Cytokine profile in the gingival crevicular fluid of periodontitis
patients with and without type 2 diabetes: a literature review. J
Periodontol. 83:156–161. 2012. View Article : Google Scholar : PubMed/NCBI
|
19
|
Kim KA, Chung SB, Hawng EY, et al:
Correlation of expression and activity of matrix
metalloproteinase-9 and −2 in human gingival cells of periodontitis
patients. J Periodontal Implant Sci. 43:24–29. 2013.
|
20
|
Seymour GJ and Gemmell E: Cytokines in
periodontal disease: where to from here? Acta Odontol Scand.
59:167–173. 2001. View Article : Google Scholar : PubMed/NCBI
|
21
|
Bartold PM and Haynes DR: Interleukin-6
production by human gingival fibroblasts. J Periodontal Res.
26:339–345. 1991. View Article : Google Scholar : PubMed/NCBI
|
22
|
Reinhardt RA, Masada MP, Kaldahl WB, et
al: Gingival fluid IL-1 and IL-6 levels in refractory
periodontitis. J Clin Periodontol. 20:225–231. 1993. View Article : Google Scholar : PubMed/NCBI
|
23
|
Botero JE, Contreras A and Parra B:
Profiling of inflammatory cytokines produced by gingival
fibroblasts after human cytomegalovirus infection. Oral Microbiol
Immunol. 23:291–298. 2008. View Article : Google Scholar : PubMed/NCBI
|
24
|
Chung RM, Grbíc JT and Lamster IB:
Interleukin-8 and beta-glucuronidase in gingival crevicular fluid.
J Clin Periodontol. 24:146–152. 1997. View Article : Google Scholar : PubMed/NCBI
|
25
|
Boström L, Linder LE and Bergström J:
Clinical expression of TNF-alpha in smoking-associated periodontal
disease. J Clin Periodontol. 25:767–773. 1998.PubMed/NCBI
|
26
|
Rossomando EF, Kennedy JE and Hadjimichael
J: Tumour necrosis factor alpha in gingival crevicular fluid as a
possible indicator of periodontal disease in humans. Arch Oral
Biol. 35:431–434. 1990. View Article : Google Scholar : PubMed/NCBI
|